AtriCure (ATRC) just cleared an important clinical milestone, reporting successful first in human atrial procedures that combine its Pulsed Field Ablation and Radiofrequency Ablation platforms, while ...

Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

AtriCure (NASDAQ:ATRC) is one of the most promising mid-cap healthcare stocks under $50. On December 16, J.P. Morgan analyst ...

If you are wondering whether AtriCure at around $40 a share is a smart buy or a value trap, you are not alone. That is exactly what we are going to unpack here. The stock is up 7.4% over the last ...

Atricure Inc. (NASDAQ: ATRC), the maker of cardiac surgical ablation systems, has received a conditional nod from the Food and Drug Administration (FDA) to evaluate the safety and efficacy of a hybrid ...

AtriCure announced the successful first-in-human AFib treatments using its novel dual-energy surgical cardiac ablation platform.

FDA approval results in the only label of its kind for more than 3 million patients in the United States, significantly expanding AtriCure’s addressable market Superiority trial showed a 29% ...

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left ...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and ...

WEST CHESTER, Ohio — AtriCure Inc. has agreed to pay the federal government $3.76 million to settle claims that it promoted its surgical cardiac ablation devices for unapproved uses, the Justice ...

Learn more about whether Alphatec Holdings, Inc. or AtriCure, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.